Fig. 2: Various treatment outcomes of patients. | Blood Cancer Journal

Fig. 2: Various treatment outcomes of patients.

From: Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis

Fig. 2: Various treatment outcomes of patients.

A Event-free survival of whole matched patients. B The reasons for the end of treatment in both treatment groups. C Hospitalization duration of patients. D RBC/platelet transfusion requirement of patients. *In patients who obtained a leukemia-free state. DEC decitabine, EFS event-free survival, F/U follow-up, HD hospitalization days, HR hazard ratio, HSCT hematopoietic stem cell transplantation, IQR interquartile range, OPD outpatient department, RBC red blood cell, T/F transfusion, VEN venetoclax.

Back to article page